Sinopharm
1099.HK
#2233
Rank
โ‚น737.72 B
Marketcap
โ‚น236.40
Share price
-0.49%
Change (1 day)
6.98%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2024: โ‚น206.13 Billion

According to Sinopharm's latest financial reports the company's current earnings are โ‚น80.09 Billion. In 2024 the company made an earning of โ‚น206.13 Billion a decrease over its 2023 earnings that were of โ‚น285.74 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2024

Annual earnings

Year Earnings Change
2024โ‚น206.13 B-27.86%
2023โ‚น285.74 B-0.73%
2022โ‚น287.85 B-1.72%
2021โ‚น292.87 B11.7%
2020โ‚น262.19 B18.44%
2019โ‚น221.36 B10.85%
2018โ‚น199.70 B3.05%
2017โ‚น193.79 B36.48%
2016โ‚น141.99 B7.11%
2015โ‚น132.57 B12.38%
2014โ‚น117.97 B25.05%
2013โ‚น94.34 B22.54%
2012โ‚น76.99 B35.43%
2011โ‚น56.84 B52.24%
2010โ‚น37.34 B30.99%
2009โ‚น28.50 B60.59%
2008โ‚น17.75 B48.29%
2007โ‚น11.97 B123.29%
2006โ‚น5.36 B